[ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device]

G Ital Cardiol (Rome). 2022 May;23(5):340-378. doi: 10.1714/3796.37817.
[Article in Italian]

Abstract

Heart failure is a complex clinical syndrome with a severe prognosis, despite therapeutic progress. The management of the advanced stages of the syndrome is particularly complex in patients who are referred to palliative care as well as in those who are candidates for cardiac replacement therapy. For the latter group, a prompt recognition of the transition to the advanced stage as well as an early referral to the centers for cardiac replacement therapy are essential elements to ensure that patients follow the most appropriate diagnostic-therapeutic pathway. The aim of this document is to focus on the main diagnostic and therapeutic aspects related to the advanced stages of heart failure and, in particular, on the management of patients who are candidates for cardiac replacement therapy.

MeSH terms

  • Cardiotonic Agents / therapeutic use
  • Critical Pathways
  • Heart Failure*
  • Heart Transplantation*
  • Heart-Assist Devices*
  • Humans
  • Palliative Care

Substances

  • Cardiotonic Agents